Marabio Systems Raised $19M In Series A For Blood Test To Detect Autism

10 Oct 2024

Marabio Systems says the new funding will help accelerate efforts to bring a blood test to market in 2025 that will accurately determine if a mother is a carrier of antibodies that cause MARA, a subtype of autism that believe to cause more severe behavior.

Marabio Systems, which developed the first blood test to detect a biological subtype of autism in mothers, recently announced it raised $19m in a series A funding round led by MAK Capital One, LLC.

The northern California-based company plans to use the proceeds to develop a precision immunology platform to diagnose autism and initial...